UV207 Fluorescent Invisible Detection Powder, Grey/green

Classification (GHS-US)

Not classified

2.2 Label elements

GHS US labeling No labeling applicable

Other hazards which do not result in classification

Epidemiological studies of workers in the Carbon Black pigment producing industries of North America and Western Europe show no significant adverse health effect due to occupational exposure to Carbon Black pigment. Early studies in the former USSR and Eastern Europe report respiratory diseases among workers exposed to Carbon Black pigment, including bronchitis, pneumonia, emphysema, and rhinitis. Such studies are of questionable validity, due to inadequate study design and methodology, lack of appropriate controls for cigarette smoking, and other confounding factors such as concurrent exposures to carbon monoxide, coal oil and petroleum vapors. Moreover, review of these studies indicates that concentrations of Carbon Black pigment are greater that current occupational exposure standards. In Monograph 65, issued in April 1996, The International Agency for Research on Cancer (IARC) re-evaluated Carbon Black pigment and concluded that: “Although one cohort study on the Carbon Black pigment production industry showed slight excesses of cancer, the totality of the epidemiology studies, both in the Carbon Black pigment industry and in some user industries, suggested that there is inadequate evidence for the carcinogenicity in humans of Black pigment. 2.4.

Ingredient(s) with unknown acute toxicity

Not applicable